Quick Answer
Nexalin Technology, Inc. reported R&D Expense of $1.08 million for fiscal year 2025.
Nexalin Technology, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.08M | -9.0% |
| 2024 | $1.19M | -38.0% |
| 2023 | $1.92M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $226.5K | +26.9% | +0.3% |
| June 30, 2025 | $225.8K | +33.3% | -44.4% |
| March 31, 2025 | $406.3K | +284.5% | +127.5% |
| September 30, 2024 | $178.6K | — | +5.4% |
| June 30, 2024 | $169.4K | — | +60.3% |
| March 31, 2024 | $105.7K | — | — |
- Nexalin Technology, Inc. showed a decrease of -9.0% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Nexalin Technology, Inc.’s r&d expense has declined by 43.6% (from $1.92 million to $1.08 million).
- The most recent figure is from Nexalin Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: